RESET-01 and what comes next.
RESET's pipeline is the asset layer of the platform. RESET-01 is the first investigational neurotherapeutic compound under our brand. Additional compounds and protocols will plug into the same operating discipline.
Our first clinical research formulation.
An investigational neurotherapeutic compound presented here for partnership and informational purposes only. Not approved for therapeutic use.
- Designation
- RESET-01 · Clinical Research Formulation
- Class
- Investigational neurotherapeutic compound
- Format
- Capsule · 30 count · 5mg active (illustrative)
- Setting
- Authorized clinical research only
- Status
- Investigational — not approved for therapeutic use
RESET-01 is an investigational neurotherapeutic compound presented here for partnership and informational purposes. It is not approved for therapeutic use. RESET makes no claim as to the safety or efficacy of any compound. Use only within authorized clinical research and physician-supervised protocols.
Formulation
Formulation
Your next chapter
starts here.
RESETIllustrative renders only. Final packaging follows manufacturer specification, jurisdictional label requirements, and counsel review.
Four disciplines, one programme.
What goes into RESET-01 as a clinical research formulation.
Clinical Grade
Built to the highest pharmaceutical standards — GMP-aligned, batch-controlled, fully traceable.
Neuroscience-Led
Targeting pathways that, in the broader scientific landscape, are associated with long-term behavioural change.
Compassion-Driven
Developed with patients, families, and clinicians — protocols designed to support whole-person recovery research.
Regulated Access
Authorized clinical research settings only. Not for use outside of approved clinical protocols.
Field, not asset.
RESET stands for addiction-recovery research as a category. Individual programmes — RESET-01 and beyond — plug into the same operating discipline.
Field, not asset
RESET stands for addiction-recovery research as a category. Individual programmes plug in.
Optionality
Multiple investigational compounds, multiple protocols, multiple jurisdictions — not a single binary outcome.
Disciplined progression
Programmes advance only as scientific, manufacturing, and regulatory evidence supports.
Build the regulated future of addiction recovery with us.
Science. Compassion. Transformation. RESET is a clinical-stage neurotherapeutics company — partner with the discipline behind a new era of recovery research.